Skip to main content
. 2020 Apr 6;11(14):4015–4022. doi: 10.7150/jca.38237

Table 2.

Crude- and multivariable-adjusted hazard ratios for cardiovascular disease according to treatment modality in prostate cancer cohort

Treatment group N Event Person year Incidence H.R (95% Confidence interval)
Crude Adjusted*
IHD No medication 1169 84 7128.83 11.78 1 Ref. Ref.
GnRH agonists 548 39 2723.23 14.32 1.257 (0.858-1.840) 1.107 (0.743-1.651)
Antiandrogen only 138 9 536.26 16.78 1.54 (0.774-3.067) 1.337 (0.661-2.706)
AMI No medication 1431 29 8865.31 3.27 1 Ref. Ref.
GnRH agonists 709 23 3549.95 6.48 1.996 (1.151-3.461) 1.503 (0.841-2.688)
Antiandrogen only 166 4 681.74 5.87 1.799 (0.631-5.127) 1.208 (0.413-3.529)

* Adjusted for all covariated in Table 1